Bridging Chemotherapy: Follicular Lymphoma, Mantle Cell Lymphoma, and CLL
Related Research units
Abstract
While lisocabtagene maraleucel (liso-cel) is the only product that is specifically approved to treat grade 3B follicular lymphoma (FL), specifically in aggressive lymphoma indications, to date, axi-cel is the first and only approved CAR-T product for indolent NHL.
Bibliographical data
| Original language | English |
|---|---|
| Title of host publication | The EBMT/EHA CAR-T Cell Handbook |
| Editors | Nicolaus Kröger, John Gribben, Christian Chabannon, Ibrahim Yakoub-Agha, Hermann Einsele |
| REQUIRED books only: Number of pages | 3 |
| Place of Publication | Cham |
| Publisher | Springer International Publishing |
| Publication date | 2022 |
| Edition | 1 |
| Pages | 123-125 |
| ISBN (Print) | 978-3-030-94352-3 |
| ISBN (Electronic) | 978-3-030-94353-0 |
| DOIs | |
| Publication status | Published - 2022 |
